OmviewThe problem
Her son had just started an ADHD medication trial, and the psychiatrist had asked her to watch closely — appetite, sleep, mood, focus, how he was at school, how he was once the dose wore off in the afternoon. Watch closely, and come back in six weeks.
So she watched. She kept a paper diary on the kitchen counter, a few scrawled words most evenings, nothing on the nights she was too tired to write. She messaged his teacher on WhatsApp, asking how he'd seemed that day, and got back fragments — “good day,” “a bit distracted after lunch,” sometimes nothing at all, buried under the rest of a school day's messages.
By the time the appointment came around, six weeks had compressed into whatever she could reconstruct in the waiting room. She tried to remember everything — the good mornings, the hard afternoons, the night he couldn't fall asleep — and she remembered some of it. Not all of it. Nobody could have.
What changed
She wasn't the only one watching. His teacher was watching. The after-school caregiver was watching. Even he, at eight years old, could tell you how his own day had felt if someone simply asked him at bedtime. The observations already existed. What was missing was somewhere for them to go.
So she built a tool. Nothing complicated — a short daily check-in for each person in her son's day, a couple of minutes at most, sent at a time that worked for them. His teacher answered a few questions after the final bell. The caregiver answered before dinner. He answered his own, shorter version at bedtime. Every day, four small pictures. Over a month, one large one.
The appointment
This time she walked in with a report instead of a memory. Thirty days of structured, dated observations from four people, laid out against the two medications he'd trialled. The psychiatrist read through it slowly, the way clinicians read something they didn't expect to see.
“The depth of information was overwhelming — in the best possible way.”
— Child and adolescent psychiatrist, Cape Town, August 2026
What it showed
Laid side by side, the two medication phases told a clear story — attention ratings that were mixed and inconsistent on the first, steadier and higher on the second, corroborated across every observer rather than resting on any one person's memory. Physical symptoms that had gone unmentioned in six-week recall showed up plainly once they were logged the day they happened.
And there, among the adult observations, was his own voice — a bedtime check-in most nights, in his own words, about how the day had actually felt from the inside. Thirty days of that, arriving all at once, gave the appointment something it had never had before: enough information to make a confident decision, together.
Omview clinical report
Attention rating — daily average
+42%
Rated attention
4/4
Observers reporting
30
Days of structured data
The tool
That tool is Omview. What started as a way for one family to get through one appointment has become a structured, multi-observer report that any family, school and clinician can use — free for families, free for schools, and built for the clinicians making the decisions in the room.
Because a medication trial shouldn't depend on how much a parent can remember at 4pm on a Tuesday. It should depend on what actually happened — recorded by everyone who was there to see it.